Dr. José Mangione Inaugurated as New SOLACI President

Dr. José Mangione, renowned Latin American interventional cardiologist of ample trajectory, is now in charge of the Latin American Interventional Cardiology’s destiny for the next two years, following Dr. José Luis Leiva Pons’ (Mexico) successful administration.

Dr. José Mangione will preside SOLACI during the term 2019-2021. PH: Antônio More / MorePress.

“I am honored and delighted to take this responsibility”, stated Dr. Mangione during the closing ceremony of SOLACI-SBHCI 2019. And added: “SOLACI has been conducted by many of the great names of Latin American Interventional Cardiology. SOLACI is a strong notable brand with a solid reputation around the world. My job will be to keep uniting cardiovascular intervention across the region.

Trained at Mogi das Cruzes University, Dr. Mangione is the former President of the Brazilian Society of Hemodynamics and Interventional Cardiology (SHBCI) in addition to having been the former Vice-President to Dr. Leiva Pons at SOLACI. Thus, he certainly knows the ropes of our society.

His first words as president emphasized the importance of hard work in the scientific area at SOLACI: “My concern, responsibility and determination is to further develop the scientific part of SOLACI, (…) we must continue working with our local societies in depth to show the world that Latin America is capable of world class interventionism”..

Dr. Leiva Pons bid farewell to SOLACI Presidency. PH: Antônio More / MorePress.

Dr. Mangione will be assisted as Vice President by Dr. Anibal Damonte, current President of the Argentinian School of Interventional Cardiologists (CACI) and founding member of SOLACI. Dr. Alfaro Marchena Noriega (Panama) will continue to be the Secretary and Dr. Omar Santaera (Argentina) will continue as our institution’s Treasurer.

On the other hand, during the closing ceremony Dr. José Luis Leiva Pons pointed out the success of SOLACI-SBHCI 2019 (“An event with excellent attendance and the presence of international professors of the highest category”), he thanked the authorities (Dra. Viviana Lemke, President of SBHCI, and Dr. Alexandre Schaan of Quadros, President of the event’s Scientific Commettee) and praised the work done throughout the year: “we have worked hard to get where we are and are extremely pleased with the result. We are grateful for the presence of you all”.

He finally said goodbye: “We leave SOLACI in great hands. See you at Buenos Aires 2020”..


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...